NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova lid and lash hygiene product for the domestic eye care market, reports financial results for the three and six months ended June 30, 2016, and provides a business update. “NovaBay achieved record Avenova sales of $2.6 million, representing a healthy 89% growth over first quarter and over a $10 million annualized run rate. We drove